(Q78235105)

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

title

Antibiotika aus Gleitenden Bakterien, LV – Myxochromid A: Ein hochungesättigtes Lipopeptidlacton ausMyxococcus virescens (English)

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25R,27S)-16-ethyl-6,8,9-trihydroxy-12-(hydroxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,20,28-trione

1 reference

(2S,6S,8S,9R,12Z,14E,16S,20S,25S,27S)-16-ethyl-6,8,9,20-tetrahydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,28-dione

1 reference

(2S,6S,8S,9R,12Z,14E,16S,20R,25R,27S)-16-ethyl-6,8,9,20-tetrahydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,28-dione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25S,27S)-16-ethyl-6,8,9-trihydroxy-25,27-dimethyl-3,20,28-trioxo-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-12-carboxylic acid

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25R,26E)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14,26-triene-3,28-dione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25R,27S)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,28-dione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25S,27S)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,28-dione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25S,27S)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,20,24,28-tetrone

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25S,27S)-6,8,9-trihydroxy-12-(methoxymethyl)-16,25,27-trimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,28-dione

1 reference

(1S,2R,4S,8S,11S,13S,22R,23E,25Z,27S)-22-ethyl-2,4-dihydroxy-27-methoxy-11,13-dimethyl-8-propyl-9,28-dioxa-6-azabicyclo[24.2.2]triaconta-23,25-diene-7,10,18-trione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25S,27S)-6,8,9-trihydroxy-12-(methoxymethyl)-16,25,27-trimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,20,28-trione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,23S,25S)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-23,25-dimethyl-2-propyl-1-oxa-4-azacyclohexacosa-12,14-diene-3,26-dione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25S,27S)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,20,28-trione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25R,26E)-16-ethyl-6,8,9-trihydroxy-12-(hydroxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14,26-triene-3,20,28-trione

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25R,27S)-6,8,9-trihydroxy-12-(methoxymethyl)-16,25,27-trimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,28-dione

1 reference

4-Demethyl-7-oxomyxovirescin G1

1 reference

(2S,6S,8S,9R,12Z,14E,16R,25R,26E)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-25,27-dimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14,26-triene-3,20,28-trione

1 reference

(2S,6S,8S,9R,12E,14E,16R,25S,27S)-16-ethyl-6,8,9-trihydroxy-12,25,27-trimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,20,28-trione

1 reference

1 reference

(2S,6S,8S,9R,12E,14E,16R,25R,26E)-16-ethyl-6,8,9-trihydroxy-12,25,27-trimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14,26-triene-3,20,28-trione

1 reference

(1S,2S,4S,8S,11S,13S,22R,23E,25R,26R)-22-ethyl-2,4,26-trihydroxy-26-(methoxymethyl)-11,13-dimethyl-8-propyl-9,29-dioxa-6-azabicyclo[23.3.1]nonacos-23-ene-7,10,18-trione

1 reference

(2S,6S,8S,9R,12E,14E,16R,25S,27S)-16-ethyl-6,8,9-trihydroxy-12,25,27-trimethyl-2-propyl-1-oxa-4-azacyclooctacosa-12,14-diene-3,20,24,28-tetrone

1 reference

1 reference

1 reference

(2S,6S,8S,9R,12Z,14E,16S,27S,29S)-16-ethyl-6,8,9-trihydroxy-12-(methoxymethyl)-27,29-dimethyl-2-propyl-1-oxa-4-azacyclotriaconta-12,14-diene-3,20,30-trione

1 reference

2

Klaus Gerth

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

3

Victor Wray

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

author name string

Wolfram Trowitzsch-Kienast

series ordinal

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

Hans Reichenbach

series ordinal

4

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

Gerhard Höfle

series ordinal

5

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

Liebigs Annalen der Chemie

12 December 2019

publication date

13 December 1993

1 reference

16 September 2022

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

volume

1993

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

issue

12

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

12 December 2019

page(s)

1233-1237

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200

The structure of syringomycins A1, E and G.

12 December 2019

cites work

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/JLAC.1993199301200

Structure of the peptide antibiotic stendomycin

9 March 2024

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/JLAC.1993199301200

Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. II. Isolation and chemical structures of megovalicins

9 March 2024

1 reference

COCI

https://opencitations.net/index/api/v1/references/10.1002/JLAC.1993199301200

9 March 2024

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1002/jlac.1993199301200